DCF — BROWARD HEALTH MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-449.7M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $546.2M | $-97.7M | -18.0% | $-120.9M | $-109.9M |
| Year 2 | $562.6M | $-95.0M | -17.0% | $-118.9M | $-98.2M |
| Year 3 | $579.5M | $-92.1M | -16.0% | $-116.6M | $-87.6M |
| Year 4 | $596.9M | $-91.9M | -15.0% | $-117.1M | $-80.0M |
| Year 5 | $614.8M | $-93.1M | -15.0% | $-119.1M | $-74.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$530.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18393001919285934
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5